Unknown PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT01790711

Fecal Microbiota Transplantation on Type 2 Diabetes Mellitus

The Efficiency of Fecal Microbiota Transplantation on Type 2 Diabetes Mellitus

Sponsor: The Second Hospital of Nanjing Medical University

Updated 6 times since 2017 Last updated: Nov 21, 2014 Started: Oct 31, 2012 Primary completion: May 31, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01790711, this PHASE2/PHASE3 trial focuses on Efficiency and Methodology and remains ongoing. Sponsored by The Second Hospital of Nanjing Medical University, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

Status: Enrolling By Invitation → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation PHASE2_PHASE3

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Second Hospital of Nanjing Medical University

Data source: The Second Hospital of Nanjing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China